Development Scientist
Momentum Bioscience Ltd
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Aram Kadoom MSc is a Development Scientist and part of the R&D team at Momentum Bioscience Ltd.; a biotechnology company based in Oxford, UK. He has expertise in the fields of Microbiology and Molecular Biology and experience working in a London clinical microbiology laboratory. Momentum Bioscience is focused on developing rapid tests for bloodstream infection in patients suspected of sepsis.
SepsiSTAT® is our direct-from-blood, rapid screening technology, providing actionable results for suspected sepsis patients.
SepsiSTAT® contains our three proprietary capabilities:
1. Sensitive and universal microbial capture
2. Universal detection of viable microorganisms (using our patented ETGA® technology)
3. Organism profiling
Only by using Momentum’s proprietary universal pathogen capture, detection & identification capabilities can all patients suspected of sepsis expect actionable results for bloodstream infection in <4 hours. Not days.
This will have a significant impact on patient management, the management of antibiotics and help mitigate the problem of increasing antimicrobial resistance.
Momentum is seeking partners for joint commercialisation.
